Our Impact

Our Impact

Every dollar raised by the Pelotonia community goes toward innovative cancer research.

In the first twelve years, the Pelotonia community raised over $217 million for innovative cancer research at The Ohio State University Comprehensive Cancer Center.

100% of all participant-raised dollars go toward innovative cancer research, including:

  • Enhanced Treatments and TherapiesPelotonia dollars help attract and retain the best talent in cancer research to explore high-impact breakthroughs that make cancer treatment less toxic and more effective.
  • The Next Generation of Research TalentPelotonia's Fellowship Program empowers young innovators across academic fields and disciplines to pursue a career in cancer research.
  • Immuno-OncologyPelotonia pioneered a landmark investment to launch the Pelotonia Institute for Immuno-Oncology.
  • Prevention and Early DiagnosisPelotonia funds initiatives that aim to save lives before cancer strikes through prevention and early detection methods.
GoLearn More about Pelotonia funded Research

100% of all participant-raised dollars go toward innovative cancer research, including:

Discover the impact of Pelotonia dollars.

The Research

Pelotonia-funded research is changing lives.

Read Stories of ImpactGo

The Institute

In July 2019, Pelotonia pledged $102,265,000 to help launch the Pelotonia Institute for Immuno-Oncology.

Learn MoreGo

2020 Pelotonia Investment Report

Pelotonia invests in high risk, high reward cancer research.

Read About the Latest DiscoveriesGo

100% of participant-raised funds go to innovative cancer research. Here's what the community has done so far:

The Pelotonia arrow embodies forward progress and reflects our relentless pursuit to achieve our shared One Goal. Help us move one step closer to that goal.

GoThe Forward Fund
100% of funds raised go to life-saving cancer research.

450 W. Broad Street, Columbus, OH | 614.221.6100

© 2021 Pelotonia. All rights reserved.

100% cancer research impact made possible by our funding partners.